To cite this paper use one of the standards below:
Melanoma is an aggressive skin cancer, with a metastatic phenotype, caused by a mutation of melanocytic cells. The chemotherapy treatment for melanoma consists in the use of highly toxic drugs, because tumor cells are resistant to most of the medications clinically used. Due to this chemoresistance, it is necessary to search for new therapeutic targets, and the rich source of secondary metabolites found in plants increase the probability to identify innovative anticancer compounds. The strategy used in the present work was to search for promising compounds by exploring the chemical composition of plants extracts belonging to different families by HPLC-DAD-MS/MS, combined with statistical analysis to identification of bioactive compounds, based on the positive correlation with the in vitro biological assay. The hydromethanolic extracts obtained by the leaves of 15 species (Anadenanthera colubrina, Aspidosperma subincanum, Cariniana estrellensis, Copaifera langsdorffii, Coussarea hydrangeifolia, Dipteryx alata, Guarea guidonia, Hymenaea stigonocarpa, Inga vera, Eugenia sp, Protium heptaphyllum, Siparuna guianensis, Tapirira guianensis, Terminalia brasiliensis and Trichilia pallida) were tested in an experimental model of murine melanoma cell line (B16F10-NEX2). Based on the results of the cytotoxicity assay and the statistical data, it was possible to perform a direct univariate correlation with the toxic effect in B16F10-NEX2 and chemical composition of the extracts. Through the analysis by HPLC-DAD-MS/MS it was possible to identify the secondary metabolites, which had a high positive correlation. The presence of some classes of secondary metabolites in the extracts has great influence on the evaluated activity. In the cytotoxicity assay, five extracts from A. subincanum, C. langsdorffii, C. hydrangeifolia, G. guidonia e T. guianensis, were able to cause damage on tumoral cells B16F10-NEX2. The compounds, found in these extracts, with the highest correlation were the flavonoids present in T. guanensis, identified as: myricetin, quercetin 3-(6-O-galloyl-β-D-galactoside), kaempferol 3-O-(2'-galloyl)-β-D-galactopyranoside, exhibiting the correlation with B16F10-NEX2 activity of 0.8, 0.79 and 0.75, respectively. Galloylquinic acid derivatives present in C. langsdorffii and T. guianensis showed significant correlation (0.47 and 0.45). Indole alkaloids found in A. subincanum, such as aspidoscarpine (0.35) and apparicine (0.33) derivatives, also have good correlation with the activity and could be responsible for the cytotoxic activity of this extract. The chemical diversity observed in this work allows the identification of potential anticancer compounds from different classes of secondary metabolites. We highlight the higher correlation of glycosylated flavonoids compared to other classes with cytotoxic activity against B16F10-NEX2 cells. For us, these compounds could be used in the development of new prototypes for the treatment of cancer. Additionally, we like to emphasize that the employed technique was essential for the identification of the active compounds in the extracts, without an isolation step, which is essential to accelerating the process of development of new drugs.
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Attention: this is not a DOI for the paper and as such cannot be used in Lattes to identify a particular work.
Check the link "How to cite" in the paper's page, to see how to properly cite the paper